Clinical CGT Immune Monitoring 
and Immunobiology Workshop 

Special Add-on Pricing with ISCT 2026

As cell and gene therapies (CGT) continue to advance, standardizing immune monitoring is critical to ensure consistent patient outcomes and generate comparable data across clinical sites. The Clinical CGT Immune Monitoring and Immunobiology Workshop is a one-day, expert-led program designed for clinicians, scientists, process development associates, laboratory directors, and medical students focused on advancing CGT patient care.

Cell Therapy Manufacturing: Operational Strategies for Success

Special Add-on Pricing with ISCT 2026

This one-day, in-person, expert-led training is designed for senior lab professionals, including lab managers, lab directors, process development associates, and quality control and quality assurance associates seeking to optimize their cell product manufacturing processes. The course focuses on critical areas within the cell manufacturing workflow where inconsistencies and challenges frequently occur.  Participants will benefit from real-world case studies presented by leading academic and industry experts from North America and Europe. 

Exosomes Scientific Signature Series

Special Add-on Pricing with ISCT 2026

The Exosomes Scientific Signature Series brings together global experts to examine the evolving science, translation, and clinical application of extracellular vesicles (EVs) and the broader secretome. The program focuses on defining and measuring active components, understanding analytical and manufacturing limitations, and interpreting early clinical experience, while addressing key challenges such as standardization, reproducibility, scalability, and regulatory expectations to support safe and consistent clinical translation.

CAR-T Scientific Signature Series

Special Add-on Pricing with ISCT 2026

The CAR-T Scientific Signature Series explores the expansion of CAR-T cell therapies beyond hematologic malignancies into new disease areas, including autoimmune, fibrotic, cardiovascular, and neurological conditions. Through expert-led discussions, the program examines emerging clinical applications, in vivo CAR-T development, trial design for novel indications, regional regulatory expectations, and reimbursement considerations shaping broader clinical adoption.